Toxin-antitoxin systems in clinical pathogens

UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.grupoInvInvestigación en Microbiología (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.issue7es_ES
UDC.journalTitleToxinses_ES
UDC.startPage227es_ES
UDC.volume8es_ES
dc.contributor.authorFernández-García, Laura
dc.contributor.authorBlasco, Lucía
dc.contributor.authorZamora López, María José
dc.contributor.authorBou, Germán
dc.contributor.authorGarcía-Contreras, Rodolfo
dc.contributor.authorWood, Thomas
dc.contributor.authorTomás, María
dc.date.accessioned2025-05-08T09:34:03Z
dc.date.available2025-05-08T09:34:03Z
dc.date.issued2016-07-20
dc.descriptionReviewes_ES
dc.description.abstract[Abstract] Toxin-antitoxin (TA) systems are prevalent in bacteria and archaea. Although not essential for normal cell growth, TA systems are implicated in multiple cellular functions associated with survival under stress conditions. Clinical strains of bacteria are currently causing major human health problems as a result of their multidrug resistance, persistence and strong pathogenicity. Here, we present a review of the TA systems described to date and their biological role in human pathogens belonging to the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) and others of clinical relevance (Escherichia coli, Burkholderia spp., Streptococcus spp. and Mycobacterium tuberculosis). Better understanding of the mechanisms of action of TA systems will enable the development of new lines of treatment for infections caused by the above-mentioned pathogens.es_ES
dc.description.sponsorshipThis work was funded by grants PI13/02390, awarded to María Tomas, the integrated National Plan for Scientific Research, Development and Technological Innovation 2008-2011 and 2013-2016, by the ISCIII-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe” and also by the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015) and by the Spanish Ministry of Health. María Tomas was financially supported by the Miguel Servet II Programme (SERGAS and ISCIII). Rodolfo García-Contreras is supported by the SEP-CONACyT Grant 152794 and by the UNAM-PAPIIT Grant IA201116. Thomas Wood was supported by the Army Research Office (W911NF-14-1-0279) and is Professor of the Biotechnology Endowed Chair at Pennsylvania State University.es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/PI13%2F02390/ES/Relación entre Quorum Sensing y mecanismos de resistencia en patógenos nosocomiales. Nuevas Terapias Antivirulentases_ES
dc.identifier.citationFernández-García L, Blasco L, Lopez M, Bou G, García-Contreras R, Wood T, Tomas M. Toxin-antitoxin systems in clinical pathogens. Toxins (Basel). 2016 Jul 20;8(7):227.es_ES
dc.identifier.doi10.3390/toxins8070227
dc.identifier.issn2072-6651
dc.identifier.urihttp://hdl.handle.net/2183/41937
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation.urihttps://doi.org/10.3390/toxins8070227es_ES
dc.rightsCreative Commons Attribution 4.0 International License (CC-BY 4.0)es_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectToxin-Antitoxines_ES
dc.subjectChromosomees_ES
dc.subjectClinicales_ES
dc.subjectPathogenses_ES
dc.subjectPersistancees_ES
dc.subjectPlasmidses_ES
dc.subjectResistancees_ES
dc.subjectVirulencees_ES
dc.titleToxin-antitoxin systems in clinical pathogenses_ES
dc.typereviewes_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
FGarcia_Toxin_2016.pdf
Size:
1017.71 KB
Format:
Adobe Portable Document Format
Description: